WHEN: Kickoff on April 6th in Boston, MA and ends April 20th in Las Vegas, NV
WHERE: Interviews available on the following mornings:
Boston, MA – Sunday, April 6th
New York City, NY– Monday, April 7th
Hackensack, NJ – Tuesday, April 8th
Washington D.C. – Wednesday, April 9th
Cleveland, OH – Thursday, April 10th
Indianapolis, IN – Friday, April 11th
Chicago, IL – Saturday, April 12th
St. Louis, MO – Saturday, April 12th
Denver, CO – Monday, April 14th
Salt Lake City, UT – Wednesday, April 16th
San Francisco, CA – Thursday, April 17th
Orange County, CA – Friday, April 18th
Phoenix, AZ – Sunday, April 20th
Las Vegas, NV – Tuesday, April 22th – Sunday, April 27th
WHO: Kenny Kane, Stupid Cancer EVP and road trip pilot
John Sabia, Road trip co-pilot and cancer advocate
Young Adult Survivors
WHY: 72,000 young adults (15 – 39 years old) are diagnosed with cancer each year. Stupid Cancer is the dominant non-profit healthcare organization giving a voice to the millions of young adults affected by cancer.
OMG2014 will take place on April 24-27, 2014 at the Palms Casino in Las Vegas, NV. A pivotal healthcare event, OMG2014 is one of the largest gatherings of young adult patients, survivors, caregivers, professionals and advocates in the world. The event inspires thousands to get organized, build community and unite as one to drive change.
# # #
About Stupid Cancer
Founded by Matthew Zachary in 2007, Stupid Cancer, a 501(c)3 non-profit organization, is the dominant healthcare brand for those affected by young adult cancer. Stupid Cancer empowers young adults affected by cancer and an estimated three million individuals directly benefit from the innovative and award-winning programs and service annually. The organization serves as a bullhorn for the young adult cancer movement. The charter is to ensure that no one goes unaware of the age-appropriate support resources they are entitled to so they can get busy living. For more information, visit www.stupidcancer.org.
About Millennium: The Takeda Oncology Company
Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May, 2008. The Company’s research, development and commercialization activities are focused in oncology. For more information, visit www.millennium.com.
About Voices Against Brain Cancer
Voices Against Brain Cancer’s mission is to help find a cure for brain cancer and brain tumors by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers affected by this devastating disease. VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/
Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.
Relevance New York
Relevance New York